The role of growth hormone in the pathogenesis of postmenopausal osteoporosis
- 1 November 1979
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 139 (11) , 1263-1265
- https://doi.org/10.1001/archinte.139.11.1263
Abstract
The secretory response of somatotrophic hormone (STH) to arginine hydrochloride stimulation (0.5 g/kg) was studied in 13 postmenopausal women. Eight showed evidence of osteoporosis, based on clinical and morphoradiological data and on metacarpal cortical thickness measurement, and 5 had normal bone mass. In addition, the response to L-dopa (500 mg) was determined in 4 of the osteoporotic subjects did not differ from those in the nonosteoporotic group, but the latter showed a significant increase over the former at 45, 60, 90 and 120 min. after stimulation. Similar findings were obtained with L-dopa stimulation. The poor secretory response of STH may be to some degree responsible for the osteopenia observed during the climateric.This publication has 5 references indexed in Scilit:
- Effect of Estrogens and Calcium Carbonate on Bone Loss in Postmenopausal WomenAnnals of Internal Medicine, 1977
- Body composition and skeletal metabolism following pituitary irradiation in acromegalyThe American Journal of Medicine, 1976
- The Arginine Provocative Test: An Aid in the Diagnosis of HyposomatotropismJournal of Clinical Endocrinology & Metabolism, 1967
- SECRETION OF HUMAN GROWTH HORMONE - PHYSIOLOGIC AND EXPERIMENTAL MODIFICATION1963
- IMMUNOASSAY OF ENDOGENOUS PLASMA INSULIN IN MANJournal of Clinical Investigation, 1960